Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
INTC
|
Venkata S M Renduchintala
Group President (TSCG) |
BUY
Exercise of conversion of derivative security
|
Direct | 29,272 Added 52.39% |
-
|
Oct 25
2016 |
|
INTC
|
Venkata S M Renduchintala
Group President (TSCG) |
SELL
Payment of exercise price or tax liability
|
Direct | 15,275 Reduced 50.77% |
$536,611
$35.13 p/Share
|
Oct 25
2016 |
|
INTC
|
Venkata S M Renduchintala
Group President (TSCG) |
BUY
Exercise of conversion of derivative security
|
Direct | 29,272 Added 52.39% |
-
|
Oct 25
2016 |
|
INTC
|
Stacy J Smith
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 2,750 Reduced 1.15% |
$96,608
$35.13 p/Share
|
Oct 25
2016 |
|
INTC
|
Stacy J Smith
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,269 Added 2.16% |
-
|
Oct 25
2016 |
|
SQ
|
Ajmere Dale
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 130,000 Added 50.0% |
-
|
Oct 25
2016 |
|
NILE
|
Philou Ventures, LLC |
BUY
Open market or private purchase
|
Direct | 500 Added 0.02% |
$325
$0.65 p/Share
|
Oct 25
2016 |
|
NILE
|
Kristine L Ault |
BUY
Open market or private purchase
|
Indirect | 500 Added 0.02% |
$325
$0.65 p/Share
|
Oct 25
2016 |
|
JEF
|
Brian P Friedman
President |
SELL
Payment of exercise price or tax liability
|
Direct | 269,394 Reduced 4.09% |
$5,053,832
$18.76 p/Share
|
Oct 25
2016 |
|
URI
|
Lawrence Keith Wimbush
Director |
SELL
Open market or private sale
|
Direct | 368 Reduced 5.95% |
$28,244
$76.75 p/Share
|
Oct 25
2016 |
|
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Open market or private purchase
|
Indirect | 2,200 Added 0.25% |
$14,212
$6.46 p/Share
|
Oct 25
2016 |
|
NEM
|
Scott P Lawson
EVP&Chief Integration Officer |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 3.24% |
$53,985
$35.99 p/Share
|
Oct 25
2016 |
|
AMGN
|
Brian M Mcnamee
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 2,109 Reduced 2.29% |
$334,825
$158.76 p/Share
|
Oct 25
2016 |
|
NKE
|
Eric D Sprunk
CHIEF OPERATING OFFICER |
SELL
Bona fide gift
|
Direct | 4,188 Reduced 1.65% |
-
|
Oct 25
2016 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 24,208 Reduced 0.02% |
$2,489,309
$102.83 p/Share
|
Oct 25
2016 |
|
COST
|
Richard M Libenson
Director |
BUY
Other acquisition or disposition
|
Indirect | 2,385 Added 3.78% |
-
|
Oct 25
2016 |
|
COST
|
Richard M Libenson
Director |
SELL
Other acquisition or disposition
|
Direct | 2,385 Reduced 34.9% |
-
|
Oct 25
2016 |
|
COST
|
Richard M Libenson
Director |
SELL
Open market or private sale
|
Indirect | 2,385 Reduced 3.93% |
$360,135
$151.0 p/Share
|
Oct 25
2016 |
|
DUSYF
|
Hun Beng (Joe) Lim
President and CEO |
SELL
Open market or private sale
|
Indirect | 3,000,000 Reduced 6.75% |
$180,000
$0.06 p/Share
|
Oct 24
2016 |
|
MS
|
Mitsubishi Ufj Financial Group Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
$0
$33.49 p/Share
|
Oct 24
2016 |
|
CRSP
|
Sven Ante Lundberg
Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect | 400 Added 0.08% |
$5,600
$14.0 p/Share
|
Oct 24
2016 |
|
CRSP
|
Sven Ante Lundberg
Chief Scientific Officer |
BUY
Conversion of derivative security
|
Direct | 55,217 Added 9.85% |
-
|
Oct 24
2016 |
|
CRSP
|
Kurt Von Emster
Director |
BUY
Open market or private purchase
|
Indirect | 56,000 Added 2.11% |
$784,000
$14.0 p/Share
|
Oct 24
2016 |
|
CRSP
|
Kurt Von Emster
Director |
BUY
Conversion of derivative security
|
Indirect | 2,545,814 Added 28.5% |
-
|
Oct 24
2016 |
|
CRSP
|
Bradley J Ph D Bolzon
Director |
BUY
Open market or private purchase
|
Indirect | 161,000 Added 2.38% |
$2,254,000
$14.0 p/Share
|
Oct 24
2016 |
|
CRSP
|
Bradley J Ph D Bolzon
Director |
BUY
Conversion of derivative security
|
Indirect | 6,508,699 Added 29.95% |
-
|
Oct 24
2016 |
|
CRSP
|
Thomas Woiwode
Director |
BUY
Open market or private purchase
|
Indirect | 161,000 Added 2.38% |
$2,254,000
$14.0 p/Share
|
Oct 24
2016 |
|
CRSP
|
Thomas Woiwode
Director |
BUY
Conversion of derivative security
|
Indirect | 6,508,699 Added 29.95% |
-
|
Oct 24
2016 |
|
AMT
|
Samme L Thompson |
SELL
Open market or private sale
|
Direct | 2,202 Reduced 12.06% |
$255,718
$116.13 p/Share
|
Oct 24
2016 |
|
INTC
|
Andy D Bryant
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 5,350 Reduced 1.3% |
$188,855
$35.3 p/Share
|
Oct 24
2016 |
|
INTC
|
Andy D Bryant
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,472 Added 2.51% |
-
|
Oct 24
2016 |
|
INTC
|
Diane M Bryant
EVP and Group President |
SELL
Payment of exercise price or tax liability
|
Direct | 3,871 Reduced 3.24% |
$136,646
$35.3 p/Share
|
Oct 24
2016 |
|
INTC
|
Diane M Bryant
EVP and Group President |
BUY
Exercise of conversion of derivative security
|
Direct | 7,417 Added 5.95% |
-
|
Oct 24
2016 |
|
INTC
|
Brian M Krzanich
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,248 Reduced 2.49% |
$326,454
$35.3 p/Share
|
Oct 24
2016 |
|
INTC
|
Brian M Krzanich
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 17,723 Added 4.62% |
-
|
Oct 24
2016 |
|
INTC
|
Stacy J Smith
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 5,883 Reduced 2.46% |
$207,670
$35.3 p/Share
|
Oct 24
2016 |
|
INTC
|
Stacy J Smith
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 11,270 Added 4.57% |
-
|
Oct 24
2016 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 24,208 Reduced 0.02% |
$2,498,750
$103.22 p/Share
|
Oct 24
2016 |
|
CRSP
|
Celgene Corp /De/
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 800,150 Added 14.2% |
$11,202,100
$14.0 p/Share
|
Oct 24
2016 |
|
CRSP
|
Celgene Corp /De/
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 4,034,830 Added 50.0% |
-
|
Oct 24
2016 |
|
CRSP
|
Glaxosmithkline PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 66,500 Added 2.02% |
$931,000
$14.0 p/Share
|
Oct 24
2016 |
|
CRSP
|
Glaxosmithkline PLC
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 3,154,127 Added 28.14% |
-
|
Oct 24
2016 |
|
CRSP
|
Simeon George |
BUY
Open market or private purchase
|
Indirect | 66,500 Added 2.02% |
$931,000
$14.0 p/Share
|
Oct 24
2016 |
|
CRSP
|
Simeon George |
BUY
Conversion of derivative security
|
Indirect | 3,154,127 Added 28.14% |
-
|
Oct 24
2016 |
|
CRSP
|
Versant Venture Capital Iv, L.P.
> 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect | 161,000 Added 2.38% |
$2,254,000
$14.0 p/Share
|
Oct 24
2016 |
|
CRSP
|
N Anthony Coles
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 70,000 Added 33.33% |
$980,000
$14.0 p/Share
|
Oct 24
2016 |
|
AYI
|
Richard K Reece
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 6,952 Added 5.03% |
-
|
Oct 24
2016 |
|
AYI
|
Richard K Reece
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 771 Reduced 0.62% |
$184,855
$239.76 p/Share
|
Oct 24
2016 |
|
AYI
|
Mark A Black
EVP |
BUY
Grant, award, or other acquisition
|
Direct | 6,952 Added 13.76% |
$1,666,811
$239.76 p/Share
|
Oct 24
2016 |
|
AYI
|
Mark A Black
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 767 Reduced 2.05% |
$183,896
$239.76 p/Share
|
Oct 24
2016 |